Atlas Trials

Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2)

Clinical trial NCT02398188 · COMPLETED

Trial details

NCT number
NCT02398188
Sponsor
Evofem Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Central Abdominal Bulging
Start date
2015-04-09
Primary completion
2015-10-29
Enrollment
793

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.